Mounjaro and treatment

Facts about Mounjaro and medically supervised treatment.

By Leanne van den Berg

• 4 articles

What is Mounjaro?

Mounjaro is a prescription medicine containing tirzepatide. At Véora, it is prescribed only after a clinical review and medical assessment by a registered clinician. Treatment is medically supervised and is combined with ongoing guidance. A prescription is issued only when the treating physician finds treatment medically appropriate. More information on the Véora website

Last updated on Sep 05, 2026

How does Mounjaro work?

Mounjaro acts on the GLP-1 and GIP hormone pathways. The public Véora FAQ explains that this can reduce hunger signals and increase feelings of fullness. Whether Mounjaro is appropriate for you is decided through an individual clinical assessment. More information on the Véora website

Last updated on Sep 05, 2026

Why does Véora focus on Mounjaro?

Véora focuses on Mounjaro (tirzepatide) and supports it with clinical review, personalised dosing decisions and ongoing guidance. The treating physician remains responsible for deciding whether treatment is medically appropriate for an individual patient. More information on the Véora website

Last updated on Sep 05, 2026

Who can use Véora’s services?

You must be at least 18 and under 65 to use the services, although a physician may depart from that age limit in individual cases on medical grounds. You must live in the Netherlands or another European country designated by Véora, and provide truthful, complete and current information. GLP-1 treatment is not suitable for everyone. The final assessment of eligibility lies exclusively with the treating physician. More information on the Véora website

Last updated on Sep 05, 2026